1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Thrombocytopenic Purpura: new trials by email Literature Review of Thrombocytopenic Purpura trials Research Report on Thrombocytopenic Purpura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) Romiplostim - Thrombocytopenic Purpura | Phase 1 / Phase 2 | Completed | Amgen | 16 | 2002-12-02 | 2023-06-26 |
Purpura, Thrombocytopenic (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Thrombocytopenia (1)
Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cytopenia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Purpura (1) · Signs and Symptoms (1) · Skin Manifestations (1) · Thrombotic Microangiopathies (1)
romiplostim (1)
Amgen (1)